Evidence map›Paper›PMID 36457868›Full record

ArticleFrontiers in neurology2022

Case report: Non-Alzheimer's disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET.

Yuki Momota, Mika Konishi, Keisuke Takahata, Taishiro Kishimoto, Toshiki Tezuka, Shogyoku Bun, Hajime Tabuchi, Daisuke Ito, Masaru Mimura

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Yuki MomotaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Mika KonishiDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Keisuke TakahataDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Taishiro KishimotoDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Toshiki TezukaDepartment of Neurology, Keio University School of Medicine, Tokyo, Japan.
Shogyoku BunDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Hajime TabuchiDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Daisuke ItoDepartment of Physiology/Memory Center, Keio University School of Medicine, Tokyo, Japan.
Masaru MimuraDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Keio University · JPDonald & Barbara Zucker School of Medicine at Hofstra/Northwell · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a patient with logopenic variant primary progressive aphasia (lv-PPA) who was diagnosed as having non-Alzheimer's disease (AD) tauopathy after multiple biophysical/biological examinations, including amyloid and

Indexed as

Alzheimer's diseasefrontotemporal lobar degenerationlogopenic variantpositron emission tomographyprimary progressive aphasiatauopathy

Identifiers

PMID36457868
PMCPMC9705984
OpenAlexW4309110041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.